Robert Rebhun

21PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Veterinary pharmacologyMolecular targetsPredictive and prognostic markersGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 18, 2026
Toxicity of Cytarabine Intravenous Constant Rate Infusion in Cats With Lymphoma.

|Jul 29, 2026
Survival outcomes of dogs with multicentric lymphoma treated with sequential half-body radiotherapy and L-CHOP without maintenance chemotherapy.

|Feb 20, 2026
Tolerability and Adverse Event Profile of Fixed Dose Rate Gemcitabine in Dogs With Neoplasia.

Evangelia J Makrygiannis, Luke Wittenburg, Carlos O Rodriguez

|Apr 16, 2025
Auranofin Induces ER Stress-Mediated Apoptosis, and Its Combination With Bortezomib Elicits Paraptosis-Like Cell Death in Malignant Canine Mammary Tumour Cells.

Yoon-Ho Suh, Se-Hoon Kim, Ki-Hoon Song

|Dec 27, 2024
Effect of glyceryl trinitrate and clevidipine administration on CT angiogram findings in dogs undergoing prostatic artery embolization for prostatic carcinoma.

Maureen A Griffin, William T N Culp, Amandeep S Chohan

|Apr 17, 2024
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.

Aryana M Razmara, Lauren E Farley, Rayna M Harris

Pageof 4

Frequent Collaborators

5 joint publications

Katherine A Skorupski

5 joint publications

Michael S Kent

4 joint publications

Sami Al-Nadaf

4 joint publications

Amandine T Lejeune